Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D006168:Guinea Pigs; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008875:Middle Aged; D009161:Mycobacterium / Q000187:drug effects*; D011485:Protein Binding; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use*; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin